The artificial sweetener aspartame has been the subject of several controversies since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. The FDA approval of aspartame was highly contested, beginning with suspicions of its involvement in brain cancer, [1] alleging that the quality of the initial research supporting its safety was inadequate and flawed, and that conflicts of interest marred the 1981 approval of aspartame, previously evaluated by two FDA panels that concluded to keep the approval on hold before further investigation. [1] [2] [3] [4] In 1987, the U.S. Government Accountability Office concluded that the food additive approval process had been followed properly for aspartame. [2] [5] The irregularities fueled a conspiracy theory, which the "Nancy Markle" email hoax circulated, along with claims—counter to the weight of medical evidence—that numerous health conditions (such as multiple sclerosis, systemic lupus, methanol toxicity, blindness, spasms, shooting pains, seizures, headaches, depression, anxiety, memory loss, birth defects, and death) [6] are caused by the consumption of aspartame in normal doses. [7] [8] [9]
Aspartame is a methyl ester of the aspartic acid/phenylalanine dipeptide. Potential health risks have been examined and dismissed by numerous scientific research projects. With the exception of the risk to those with phenylketonuria, aspartame is considered to be a safe food additive by governments worldwide and major health and food safety organizations. [2] [10] [11] [12] [13] [14] FDA officials describe aspartame as "one of the most thoroughly tested and studied food additives the agency has ever approved" and its safety as "clear cut." [4] The weight of existing scientific evidence indicates that aspartame is safe as a non-nutritive sweetener. [10]
The controversy over aspartame safety originated in perceived irregularities in the aspartame approval process during the 1970s and early 1980s, including allegations of a revolving door relationship between regulators and industry and claims that aspartame producer G.D. Searle had withheld and falsified safety data. In 1996, the controversy reached a wider audience with a 60 Minutes report [1] that discussed criticisms of the FDA approval process and concerns that aspartame could cause brain tumors in humans. The 60 Minutes special stated that "aspartame's approval was one of the most contested in FDA history." [1]
Around the same time, a Usenet post was widely circulated under the pen name "Nancy Markle", creating the basis for a misleading and unverifiable hoax chain letter that was spread through the Internet. [12] Numerous websites have spread the email's claims, which were not supported by scientific evidence, about safety issues purportedly linked to aspartame, including Gulf War Syndrome and lupus. [15]
Aspartame was originally approved for use in dry foods in 1974 by then FDA Commissioner Alexander Schmidt after review by the FDA's Center for Food Safety and Applied Nutrition. Searle had submitted 168 studies [2] : 20 on aspartame, including seven animal studies that were considered crucial by the FDA. [2] : 21 Soon afterwards, John Olney, a professor of psychiatry and prominent critic of MSG, along with James Turner, a public-interest lawyer and author of an anti-food-additive book, filed a petition for a public hearing, citing safety concerns. [2] : 38 [16] : 63–64 Other criticisms presented in the 1996 60 Minutes special of the Searle studies included assertions of unreported medical treatments that may have affected the study outcomes and discrepancies in the reported data. [1] Schmidt agreed, pending an investigation into alleged improprieties in safety studies for aspartame and several drugs. In December 1975, the FDA placed a stay on the aspartame approval, preventing Searle from marketing aspartame. [2] : 28 The Searle studies were criticized by the FDA commissioner as "... at best ... sloppy and suffering from ... a pattern of conduct which compromises the scientific integrity of the studies." [1]
U.S. Attorney Samuel Skinner was requested to "open a grand jury investigation into whether two of Searle's aspartame studies had been falsified or were incomplete." [17] Skinner withdrew from the case when he was considering a job offer from the law firm Sidley & Austin, Searle's Chicago-based law firm, a job he later took. [1] The investigation was delayed and eventually the statute of limitations on the charges against Searle expired [1] and a grand jury was never convened. [17]
In 1977 and 1978, an FDA task force and a panel of academic pathologists reviewed 15 aspartame studies by Searle, and concluded that, although there were major lapses in quality control, the resulting inconsistencies would not have affected the studies' conclusions. [2] : 4 In 1980, a Public Board of Inquiry (PBOI) heard testimony from Olney and disagreed with his claims that aspartame could cause brain damage, including in the developing fetus. [2] : 40–41 The board decided that further study was needed on a postulated connection between aspartame and brain tumors, and revoked approval of aspartame. [2] : 47
In 1981, FDA Commissioner Arthur Hull Hayes sought advice on the issue from a panel of FDA scientists and a lawyer. The panel identified errors underlying the PBOI conclusion that aspartame might cause brain tumors, and presented arguments both for and against approval. [2] : 53 Hayes approved the use of aspartame in dry foods. Hayes further justified his approval by citing the results of a Japanese brain tumor study, [18] the results of which, the PBOI chairman later said, would have resulted in an "unqualified approval" from the PBOI panel. [19] Several objections followed, but all were denied. [2] : 13 In November 1983, about a year after approving aspartame, Hayes left the FDA and joined the public-relations firm Burson-Marsteller, Searle's public relations agency at the time, as a senior medical adviser. [5]
The actions of Samuel Skinner, in taking a job with a law firm retained by Searle during an investigation into Searle, and Arthur Hull Hayes, in taking a job with Searle's public relations agency following aspartame's approval, fueled conspiracy theories. [17]
Because of the approval controversy, Senator Howard M. Metzenbaum requested an investigation by the U.S. Government Accountability Office (GAO) of aspartame's approval. In 1987, the GAO reported that protocol had been followed and provided a time-line of events in the approval process. [2] : 13 The GAO review included a survey of scientists who had conducted safety reviews; of the 67 scientists who responded to a questionnaire, 12 had major concerns about aspartame's safety, 26 were somewhat concerned but generally confident in aspartame safety, and 29 were very confident in aspartame safety. [2] : 16, 76–81
Food additive safety evaluations by many countries have led to approval of aspartame, citing the general lack of adverse effects following consumption in reasonable quantities. [20] Based on government research reviews and recommendations from advisory bodies such as those listed above, aspartame has been found to be safe for human consumption by more than ninety countries worldwide. [13] [14]
In 1976, the FDA notified then-U.S. attorney for Chicago, Sam Skinner, of the ongoing investigation of Searle, and in January 1977, formally requested that a grand jury be convened. In February, 1977, Searle's law firm, Sidley & Austin offered Skinner a job and Skinner recused himself from the case. [21] Mr. Skinner's successor was in place several months later, and the statute of limitations for the alleged offenses expired in October 1977. Despite complaints and urging from DOJ in Washington, neither the interim U.S. attorney for Chicago, William Conlon, nor Skinner's successor, Thomas Sullivan, convened a grand jury. [22] In December 1977, Sullivan ordered the case dropped for lack of evidence. A year and a half later, Conlon also was hired by Sidley & Austin. [17] Concern about conflict of interest in this case inflamed the controversy, and Senator Metzenbaum investigated in 1981 Senate Hearings. [2] In 1989, the U.S. Senate approved the nomination of Sam Skinner to be Secretary of Transportation, noting that both Sullivan and Senator Metzenbaum had concluded that Skinner had not acted improperly. [21]
Ralph G. Walton, a psychiatrist at Northeastern Ohio Universities College of Medicine, stated in a self-published 1996 analysis of aspartame research that industry-funded studies found no safety concerns while 84 of 92 independent studies did identify safety concerns. [17] [23] This analysis by Walton was submitted to the television show 60 Minutes and has been extensively discussed on the Internet. An analysis of Walton's claims showed that Walton left out at least 50 peer-reviewed safety studies from his review of the literature and that most of the research he cites as non-industry funded were actually letters to the editors, case reports, review articles or book chapters rather than published studies. [24] In a rebuttal to Walton's statements, the Aspartame Information Service (a service provided by Ajinomoto, a primary producer and supplier of aspartame), reviewed the publications Walton cites as critical of aspartame, arguing that most of them do not involve aspartame or do not draw negative conclusions, are not peer-reviewed, are anecdotal, or are duplicates. [25]
An elaborate health scare, [7] involving a hoax conspiracy theory disseminated on many websites in 1999, attributes a host of deleterious medical effects to aspartame. This theory claims that the FDA approval process of aspartame was tainted [12] [26] [27] and cites as its source an email based upon a supposed talk by a "Nancy Markle" (thought to be Betty Martini, who first circulated the email) [28] at a "World Environmental Conference." [12] [26] [29] Specifically, the hoax websites allege that aspartame is responsible for multiple sclerosis, systemic lupus, and methanol toxicity, causing "blindness, spasms, shooting pains, seizures, headaches, depression, anxiety, memory loss, birth defects" and death. [6] A proliferation of websites, many with sensationalist URLs, are filled with anecdotal claims and medical misinformation. [30] The Markle hoax and its extended argument on "aspartamekills.com" have not been supported by medical studies. [31] The email has been described as an "Internet smear campaign ... Its contents were entirely false, misleading, and defamatory to various popular products and their manufacturers, with no basis whatever in fact." [8]
The "Markle" email says that there is a conspiracy between the FDA and the producers of aspartame, and the conspiracy theory has become a canonical example discussed on several Internet conspiracy theory and urban legend websites. [12] [32] Although most of the allegations of this theory contradict the bulk of medical evidence, [26] the misinformation has spread around the world as chain emails since mid-December 1998, [12] influencing many websites [32] as an urban legend that continues to scare consumers. [26] The Media Awareness Network featured one version of it in a tutorial on how to determine the credibility of a web page. The tutorial implied that the "Markle" letter was not credible and stated that it should not be used as an authoritative source of information. [6]
Dean Edell warned very strongly against the "Markle" letter:
In 1997, due to public concerns, the U.K. government introduced a new regulation obliging food makers who use sweeteners to state clearly next to the name of their product the phrase "with sweeteners." [33]
In 2007, the Indonesian government considered banning aspartame. [34] In the Philippines, the small political party Alliance for Rural Concerns introduced House Bill 4747 in 2008 with the aim of having aspartame banned from the food supply. [35] In the U.S. state of New Mexico a bill to ban aspartame was introduced in 2007, and subsequently rejected. [36] [37] A similar 2008 Hawaii bill stalled in committee for lack of evidence. [38] [39] In March 2009, the California OEHHA identified aspartame as a chemical for consultation by its Carcinogen Identification Committee, in accordance with California state Proposition 65, [40] and it was reviewed at the November 15, 2016 meeting. [41]
In 2007, the U.K. supermarket chains Sainsbury's, Marks & Spencer, [42] and Wal-Mart subsidiary Asda, announced that they would no longer use aspartame in their own label products. In April 2009, Ajinomoto Sweeteners Europe, one of the makers of aspartame in Europe, responded to Asda's "no nasties" campaign by filing a complaint of malicious falsehood against Asda in the English courts. [43] [44] In July 2009, Asda initially won the legal case after the trial judge construed the "no nasties" labelling to "not mean that aspartame was potentially harmful or unhealthy." [45] [46] The decision was reversed in June 2010, upon appeal, [47] and was settled in 2011 with ASDA removing references to aspartame from its packaging. [48]
In 2009, the South African retailer Woolworths announced it was removing aspartame-containing foods from its own-brand range. [49]
In 2010, the British Food Standards Agency funded a clinical study of people who claimed to experience side-effects after consuming aspartame. [50] The double blind controlled study has been concluded and found no evidence of safety issues or side effects even amongst those volunteers who had previously claimed sensitivity. The FSA's Committee on Toxicity evaluated the results at its meeting in October 2013, and determined that "the results presented did not indicate any need for action to protect the health of the public." [51]
The European Food Safety Authority (EFSA) commenced a re-evaluation of aspartame as part of the systematic re-evaluation of all food additives authorized in the EU prior to 20 January 2009. In May 2011, EFSA was asked by the European Commission to bring forward the full re-evaluation of the safety of aspartame (E 951), which was previously planned for completion by 2020. [52] In September 2011, the EFSA made all 600 datasets it is using in its full re-evaluation available publicly. This includes previously unpublished scientific data, "including the 112 original studies on aspartame which were submitted to support the request for authorization of aspartame in Europe in the early 1980s." [53] [54] [55] On January 8, 2013, the EFSA released its draft report, which found that aspartame and its metabolites "pose no toxicity concern for consumers at current levels of exposure. The current Acceptable Daily Intake (ADI) is considered to be safe for the general population and consumer exposure to aspartame is below this ADI." [52] [56]
The Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation of Oncology and Environmental Sciences (ERF) published studies claiming aspartame increases several malignancies in rodents, concluding it a potential carcinogen at normal dietary doses. [57] [58] An open letter from the Center for Science in the Public Interest (CSPI) to the FDA endorsed by thirteen occupational safety and health experts expressed the ERF studies merited reevaluation of aspartame's safety in humans. [59] [60] [61]
After reviewing the foundation's claims, the EFSA [62] and the FDA [63] discounted the study results finding significant methodological issues as reason to retain their previously established acceptable daily intake levels for aspartame. Incomplete release of all data, including pathology slides, by the ERF restricted FDA [63] and EFSA review. [64] Based upon the data provided, the ERF's published conclusions were not supportable. The regulatory agencies Health Canada [65] and the British Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment [66] likewise found the methodological problems in the research justified rejecting the claims and retaining established policy.
Contemporaneous with the FDA and ESFA reviews, the Ajinomoto Company, Inc.—a developer of aspartame—commissioned a review through the safety and regulatory consulting firm, Burdock Group. A blind safety review by a ten-member, international panel of experts (Magnuson) of the scientific literature concurred with the regulatory agency evaluations finding many flaws in the study's design, implementation, and conclusions. [10] These included unspecified composition of the "Corticella" diet and method of adding aspartame, leading to possible nutritional deficiencies; a contamination issue from unspecified aspartame storage conditions and handling; ignoring several industry standards—lack of animal randomization, use of the institute's randomly bred lines that remained pathogen carriers as opposed to readily available pathogen-free animals, use of full-life animals resulting in age variation at death and comparing those animals to younger controls, and both high-density housing and housing of different animal groups in different conditions; an unusually high incidence of confounding infections known to cause lymphoid neoplasmas and other lesions earlier and at greater rates in the test species; pooling of tumors (lymphomas and leukemias) from different tissue types despite standing research that induced tumors "can and should be differentiated from naturally occurring tumors"; [10] : 667 insufficient/incomplete/conflicting methodology and data collection/reporting in multiple areas; and the U.S. National Toxicology Program's finding that the ERF had misdiagnosed hyperplasias as malignancies. Finding comprehensive contradiction in the research literature of any reasonable danger, in combination with the ERF's design and implementation issues, Magnuson concluded the research did not constitute credible evidence for the carcinogenicity of aspartame. Another review criticized the ERF for relying on "science by press conference" with its release of results through the media before being published in a proper peer-reviewed journal, thus helping fuel the controversy and publicity about the study in the media. [67]
The EFSA evaluated other studies published by the ERF in 2010, finding continued multiple, significant design flaws prohibiting interpretation and being insufficient to influence reconsideration of the aspartame controversy. [68]
In July 2023, scientists for the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) concluded that there was "limited evidence" for aspartame causing cancer in humans, classifying the sweetener as possibly carcinogenic. [69] [70] The Joint FAO/WHO Expert Committee on Food Additives (JECFA) stated that the limited cancer assessment confirmed there was no reason to change the recommended acceptable daily intake level of 40 mg per kg of body weight per day, reaffirming the safety of consuming aspartame within this limit. [70]
The US Food and Drug Administration (FDA) responded to the report by stating that "Aspartame being labeled by IARC as "possibly carcinogenic to humans" does not mean that aspartame is actually linked to cancer. The FDA disagrees with IARC's conclusion that these studies support classifying aspartame as a possible carcinogen to humans. FDA scientists reviewed the scientific information included in IARC's review in 2021 when it was first made available and identified significant shortcomings in the studies on which IARC relied." [71]
Aspartame is an artificial non-saccharide sweetener 200 times sweeter than sucrose and is commonly used as a sugar substitute in foods and beverages. It is a methyl ester of the aspartic acid/phenylalanine dipeptide with brand names NutraSweet, Equal, and Canderel. Aspartame was approved by the US Food and Drug Administration (FDA) in 1974, and then again in 1981, after approval was revoked in 1980.
Food additives are substances added to food to preserve flavor or enhance taste, appearance, or other sensory qualities. Some additives have been used for centuries as part of an effort to preserve food, for example vinegar (pickling), salt (salting), smoke (smoking), sugar (crystallization), etc. This allows for longer-lasting foods such as bacon, sweets or wines. With the advent of ultra-processed foods in the second half of the twentieth century, many additives have been introduced, of both natural and artificial origin. Food additives also include substances that may be introduced to food indirectly in the manufacturing process, through packaging, or during storage or transport.
Stevia is a sweet sugar substitute that is about 50 to 300 times sweeter than sugar. It is extracted from the leaves of Stevia rebaudiana, a plant native to areas of Paraguay and Brazil in the southern Amazon rainforest. The active compounds in stevia are steviol glycosides. Stevia is heat-stable, pH-stable, and not fermentable. Humans cannot metabolize the glycosides in stevia, and therefore it has zero calories. Its taste has a slower onset and longer duration than that of sugar, and at high concentrations some of its extracts may have an aftertaste described as licorice-like or bitter. Stevia is used in sugar- and calorie-reduced food and beverage products as an alternative for variants with sugar.
Sucralose is an artificial sweetener and sugar substitute. As the majority of ingested sucralose is not metabolized by the body, it adds very little food energy. In the European Union, it is also known under the E number E955. It is produced by chlorination of sucrose, selectively replacing three of the hydroxy groups—in the C1 and C6 positions of the fructose portion and the C4 position of the glucose portion—to give a 1,6-dichloro-1,6-dideoxyfructose–4-chloro-4-deoxygalactose disaccharide. Sucralose is about 600 times sweeter than sucrose, 3 times as sweet as both aspartame and acesulfame potassium, and 2 times as sweet as sodium saccharin.
A sugar substitute is a food additive that provides a sweetness like that of sugar while containing significantly less food energy than sugar-based sweeteners, making it a zero-calorie or low-calorie sweetener. Artificial sweeteners may be derived through manufacturing of plant extracts or processed by chemical synthesis. Sugar substitute products are commercially available in various forms, such as small pills, powders, and packets.
Food coloring, color additive or colorant is any dye, pigment, or substance that imparts color when it is added to food or beverages. Colorants can be supplied as liquids, powders, gels, or pastes. Food coloring is commonly used in commercial products and in domestic cooking.
Quinoline Yellow WS is a mixture of organic compounds derived from the dye Quinoline Yellow SS. Owing to the presence of sulfonate groups, the WS dyes are water-soluble (WS). It is a mixture of disulfonates (principally), monosulfonates and trisulfonates of 2-(2-quinolyl)indan-1,3-dione with a maximum absorption wavelength of 416 nm.p. 119
Cyclamate is an artificial sweetener. It is 30–50 times sweeter than sucrose, making it the least potent of the commercially used artificial sweeteners. It is often used with other artificial sweeteners, especially saccharin; the mixture of 10 parts cyclamate to 1 part saccharin is common and masks the off-tastes of both sweeteners. It is less expensive than most sweeteners, including sucralose, and is stable under heating. Safety concerns led to it being banned in a few countries, though the European Union considers it safe.
Neohesperidin dihydrochalcone, sometimes abbreviated to neohesperidin DC or simply NHDC, is an artificial sweetener derived from citrus.
Saccharin, also called saccharine, benzosulfimide, or E954, or used in saccharin sodium or saccharin calcium forms, is a non-nutritive artificial sweetener. Saccharin is a sultam that is about 500 times sweeter than sucrose, but has a bitter or metallic aftertaste, especially at high concentrations. It is used to sweeten products, such as drinks, candies, baked goods, tobacco products, excipients, and for masking the bitter taste of some medicines. It appears as white crystals and is odorless.
Acesulfame potassium, also known as acesulfame K or Ace K, is a synthetic calorie-free sugar substitute often marketed under the trade names Sunett and Sweet One. In the European Union, it is known under the E number E950. It was discovered accidentally in 1967 by German chemist Karl Clauss at Hoechst AG. Acesulfame potassium is the potassium salt of 6-methyl-1,2,3-oxathiazine-4(3H)-one 2,2-dioxide. It is a white crystalline powder with molecular formula C
4H
4KNO
4S and a molecular weight of 201.24 g/mol.
Neotame, also known by the brand name Newtame, is a non-caloric artificial sweetener and aspartame analog by NutraSweet. By mass, it is 7,000 to 13,000 times sweeter than sucrose. It has no notable off-flavors when compared to sucrose. It enhances original food flavors. It can be used alone, but is often mixed with other sweeteners to increase their individual sweetness and decrease their off-flavors. It is chemically somewhat more stable than aspartame. Its use can be cost effective in comparison to other sweeteners as smaller amounts of neotame are needed.
Diet Pepsi, currently stylised in all caps as Pepsi Diet, is a diet carbonated cola soft drink produced by PepsiCo, introduced in 1964 as a variant of Pepsi with no sugar. First test marketed in 1963 under the name Patio Diet Cola, it was re-branded as Diet Pepsi the following year, becoming the first diet cola to be distributed on a national scale in the United States. In the 1960s and 1970s, its competition consisted of the Coca-Cola Company's subsequently discontinued Tab. The United States represents the largest single market for Diet Pepsi.
Ajinomoto Co., Inc. is a Japanese multinational food and biotechnology corporation which produces seasonings, interlayer insulating materials for semiconductor packages for use in personal computers, cooking oils, frozen foods, beverages, sweeteners, amino acids, and pharmaceuticals. Aji-No-Moto is the trade name for the company's original monosodium glutamate (MSG) product, the first of its kind, since 1909. The corporation's head office is located in Chūō, Tokyo. As of 2023, Ajinomoto operates in 34 countries worldwide and employs an estimated 34,615 people. Its yearly revenue in 2023 is around ¥1.44 trillion JPY or $9.1 billion USD.
The International Agency for Research on Cancer is an intergovernmental agency forming part of the World Health Organization of the United Nations. Its role is to conduct and coordinate research into the causes of cancer. It also collects and publishes surveillance data regarding the occurrence of cancer worldwide.
tert-Butylhydroquinone is a synthetic aromatic organic compound which is a type of phenol. It is a derivative of hydroquinone, substituted with a tert-butyl group.
Polyglycerol polyricinoleate (PGPR), E476, is an emulsifier made from glycerol and fatty acids. In chocolate, compound chocolate and similar coatings, PGPR is mainly used with another substance like lecithin to reduce viscosity. It is used at low levels, and works by decreasing the friction between the solid particles in molten chocolate, reducing the yield stress so that it flows more easily, approaching the behaviour of a Newtonian fluid. It can also be used as an emulsifier in spreads and in salad dressings, or to improve the texture of baked goods. It is made up of a short chain of glycerol molecules connected by ether bonds, with ricinoleic acid side chains connected by ester bonds.
4-Methylimidazole is a heterocyclic organic chemical compound with molecular formula H
3C–C
3H
3N
2 or C
4H
6N
2. It is formally derived from imidazole through replacement of the hydrogen in position 4 by a methyl group. It is a slightly yellowish solid.
Saccharin Study and Labeling Act of 1977 or Saccharin Study, Labeling and Advertising Act was a United States federal statute endorsing requirements for a scientific observation regarding the impurities in, potential toxicity, and problematic carcinogenicity of a non-nutritive sweetener better known as saccharin. The Act of Congress invoked an immediate eighteen month moratorium prohibiting the Secretary of Health, Education, and Welfare from pursuing regulatory implications by limiting the production and use of saccharin. The Act codified a warning label requirement advocating the non-nutritive sweetener had been discovered to yield carcinogenicity in laboratory animals.
Advantame is a non-caloric artificial sweetener and aspartame analog by Ajinomoto. By mass, it is about 20,000 times sweeter than sucrose and about 110 times sweeter than aspartame. It has no notable off-flavors when compared to sucrose and tastes sweet a bit longer than aspartame and is chemically more stable. It can be blended with many other natural and artificial sweeteners.
In this and similar cases, all the Nancy Markles of the world have to do to fabricate a health rumor is post it in some Usenet news groups and let ordinary folks, who may already distrust artificial products, forward it to all their friends and e-mail pals.
First off...this text was not written by "Nancy Markle"—whoever that may be. Its real author was one Betty Martini, who posted a host of similar messages to Usenet newsgroups in late 1995 and early 1996.